SHCM
BMY icon

Sachem Head Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Sachem Head Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,070,000
Closed -$113M – 13
2017
Q1 		$113M Buy
+2,070,000
New +$114M 3.65% 11

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sachem Head Capital Management's BMY Position: Q2 2017 in Review

Sachem Head Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 2,070,000 shares — an estimated $113M sold.

Sachem Head Capital Management first reported a position in BMY in Q1 2017 and held it in 1 quarter. The position peaked at $113M in Q1 2017. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

  • Sachem Head Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
  • Sachem Head Capital Management sold 2,070,000 Bristol-Myers Squibb shares in Q2 2017, an estimated $113M.
  • Sachem Head Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 1 quarter.
  • Sachem Head Capital Management's Bristol-Myers Squibb position peaked at $113M in Q1 2017.
  • 1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Sachem Head Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.